Catalyst Biosciences, Inc. (CBIO): Price and Financial Metrics

CBIO POWR Grades

• CBIO scores best on the Value dimension, with a Value rank ahead of 88.68% of US stocks.
• CBIO's strongest trending metric is Value; it's been moving up over the last 120 days.
• CBIO's current lowest rank is in the Stability metric (where it is better than 3.28% of US stocks).

CBIO Stock Summary

• With a price/earnings ratio of 0.81, CATALYST BIOSCIENCES INC P/E ratio is greater than that of about only 0.41% of stocks in our set with positive earnings.
• Of note is the ratio of CATALYST BIOSCIENCES INC's sales and general administrative expense to its total operating expenses; merely 0.07% of US stocks have a lower such ratio.
• The ratio of debt to operating expenses for CATALYST BIOSCIENCES INC is higher than it is for about only 0.42% of US stocks.
• Stocks that are quantitatively similar to CBIO, based on their financial statements, market capitalization, and price volatility, are HBM, CGAU, INVA, ASPS, and AEHL.
• CBIO's SEC filings can be seen here. And to visit CATALYST BIOSCIENCES INC's official web site, go to www.catalystbiosciences.com.

CBIO Valuation Summary

• CBIO's price/earnings ratio is 0.7; this is 96.92% lower than that of the median Healthcare stock.
• CBIO's price/sales ratio has moved down 137.6 over the prior 204 months.

Below are key valuation metrics over time for CBIO.

CBIO Growth Metrics

The 2 year net cashflow from operations growth rate now stands at -113.63%.
• The 3 year net cashflow from operations growth rate now stands at -86.05%.
• The 4 year net cashflow from operations growth rate now stands at -85.6%.

Over the past 15 months, CBIO's revenue has gone down $2,289,000.

The table below shows CBIO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	3.234	-49.297	11.883
2022-06-30	5.533	-63.62	-8.471
2022-03-31	6.665	-71.449	-80.031
2021-12-31	7.338	-83.755	-87.933
2021-09-30	6.929	-88.193	-86.511
2021-06-30	5.523	-79.601	-77.306

CBIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CBIO has a Quality Grade of F, ranking ahead of 3.39% of graded US stocks.
• CBIO's asset turnover comes in at 0.052 -- ranking 319th of 680 Pharmaceutical Products stocks.
• LIFE, GLYC, and CLSD are the stocks whose asset turnover ratios are most correlated with CBIO.

The table below shows CBIO's key quality metrics over time.